These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22211979)

  • 21. Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune-Oncology Studies Evaluating New Therapeutic Agents.
    Verma B; Wesa A
    Curr Protoc Pharmacol; 2020 Jun; 89(1):e77. PubMed ID: 32453514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-2 receptor γ-chain molecule is critical for intestinal T-cell reconstitution in humanized mice.
    Denton PW; Nochi T; Lim A; Krisko JF; Martinez-Torres F; Choudhary SK; Wahl A; Olesen R; Zou W; Di Santo JP; Margolis DM; Garcia JV
    Mucosal Immunol; 2012 Sep; 5(5):555-66. PubMed ID: 22569301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-transplantation of human fetal thymus, bone and CD34(+) cells into young adult immunodeficient NOD/SCID IL2Rγ(null) mice optimizes humanized mice that mount adaptive antibody responses.
    Chung YS; Son JK; Choi B; Joo SY; Lee YS; Park JB; Moon H; Kim TJ; Kim SH; Hong S; Chang J; Kang MS; Kim SJ
    Clin Immunol; 2015 Apr; 157(2):156-65. PubMed ID: 25725428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Creation of "humanized" mice to study human immunity.
    Pearson T; Greiner DL; Shultz LD
    Curr Protoc Immunol; 2008 May; Chapter 15():15.21.1-15.21.21. PubMed ID: 18491294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells.
    Shultz LD; Lyons BL; Burzenski LM; Gott B; Chen X; Chaleff S; Kotb M; Gillies SD; King M; Mangada J; Greiner DL; Handgretinger R
    J Immunol; 2005 May; 174(10):6477-89. PubMed ID: 15879151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term human CD34+ stem cell-engrafted nonobese diabetic/SCID/IL-2R gamma(null) mice show impaired CD8+ T cell maintenance and a functional arrest of immature NK cells.
    André MC; Erbacher A; Gille C; Schmauke V; Goecke B; Hohberger A; Mang P; Wilhelm A; Mueller I; Herr W; Lang P; Handgretinger R; Hartwig UF
    J Immunol; 2010 Sep; 185(5):2710-20. PubMed ID: 20668220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of glucocorticoid receptor shows negative correlation with human B-cell engraftment in PBMC-transplanted NOGhIL-4-Tg mice.
    Seki T; Miyamoto A; Ohshima S; Ohno Y; Yasuda A; Tokuda Y; Ando K; Kametani Y
    Biosci Trends; 2018 Jul; 12(3):247-256. PubMed ID: 29806632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient xenoengraftment in severe immunodeficient NOD/Shi-scid IL2rγnull mice is attributed to a lack of CD11c+B220+CD122+ cells.
    Ito R; Katano I; Ida-Tanaka M; Kamisako T; Kawai K; Suemizu H; Aiso S; Ito M
    J Immunol; 2012 Nov; 189(9):4313-20. PubMed ID: 23018460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses.
    Watanabe S; Terashima K; Ohta S; Horibata S; Yajima M; Shiozawa Y; Dewan MZ; Yu Z; Ito M; Morio T; Shimizu N; Honda M; Yamamoto N
    Blood; 2007 Jan; 109(1):212-8. PubMed ID: 16954502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of hematopoietic humanized mice in the newborn BALB/c-Rag2null Il2rγnull mouse model: a multivariable optimization approach.
    Lang J; Weiss N; Freed BM; Torres RM; Pelanda R
    Clin Immunol; 2011 Jul; 140(1):102-16. PubMed ID: 21536497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice.
    Simpson-Abelson MR; Sonnenberg GF; Takita H; Yokota SJ; Conway TF; Kelleher RJ; Shultz LD; Barcos M; Bankert RB
    J Immunol; 2008 May; 180(10):7009-18. PubMed ID: 18453623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrahepatic transplantation of cord blood CD34+ cells into newborn NOD/SCID-IL2Rγ(null) mice allows efficient multi-organ and multi-lineage hematopoietic engraftment without accessory cells.
    Navarro-Montero O; Romero-Moya D; Montes R; Ramos-Mejía V; Bueno C; Real PJ; Menendez P
    Clin Immunol; 2012 Nov; 145(2):89-91. PubMed ID: 22964517
    [No Abstract]   [Full Text] [Related]  

  • 33. Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ(null) humanized mice.
    Billerbeck E; Barry WT; Mu K; Dorner M; Rice CM; Ploss A
    Blood; 2011 Mar; 117(11):3076-86. PubMed ID: 21252091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basic concept of development and practical application of animal models for human diseases.
    Nomura T; Tamaoki N; Takakura A; Suemizu H
    Curr Top Microbiol Immunol; 2008; 324():1-24. PubMed ID: 18481450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating Human Immune Responses for Vaccine Development in a Novel Human Spleen Cell-Engrafted NOD-SCID-IL2rγNull Mouse Model.
    Ghosn S; Chamat S; Prieur E; Stephan A; Druilhe P; Bouharoun-Tayoun H
    Front Immunol; 2018; 9():601. PubMed ID: 29628927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular-based therapies to prevent or reduce thrombocytopenia.
    Pineault N; Boyer L
    Transfusion; 2011 Nov; 51 Suppl 4():72S-81S. PubMed ID: 22074630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo.
    Ito A; Ishida T; Utsunomiya A; Sato F; Mori F; Yano H; Inagaki A; Suzuki S; Takino H; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
    J Immunol; 2009 Oct; 183(7):4782-91. PubMed ID: 19748990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic human T cell developmental processes in humanized mice cotransplanted with human fetal thymus/liver tissue and hematopoietic stem cells.
    Joo SY; Chung YS; Choi B; Kim M; Kim JH; Jun TG; Chang J; Sprent J; Surh CD; Joh JW; Kim SJ
    Transplantation; 2012 Dec; 94(11):1095-102. PubMed ID: 23222735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.
    Distler E; Wölfel C; Köhler S; Nonn M; Kaus N; Schnürer E; Meyer RG; Wehler TC; Huber C; Wölfel T; Hartwig UF; Herr W
    Exp Hematol; 2008 Apr; 36(4):451-63. PubMed ID: 18261837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice.
    Shultz LD; Saito Y; Najima Y; Tanaka S; Ochi T; Tomizawa M; Doi T; Sone A; Suzuki N; Fujiwara H; Yasukawa M; Ishikawa F
    Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13022-7. PubMed ID: 20615947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.